Published in J Acquir Immune Defic Syndr Hum Retrovirol on April 15, 1999
HIV Infection and AIDS in the Deep South. Am J Public Health (2006) 2.46
Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health (2002) 2.15
Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors? J Gen Intern Med (2004) 1.71
Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health (2005) 1.28
Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS. J Gen Intern Med (2001) 1.19
The role of cultural distance between patient and provider in explaining racial/ethnic disparities in HIV care. Patient Educ Couns (2011) 1.03
Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among Medicaid beneficiaries with AIDS. Am J Public Health (2001) 0.94
Community poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004. Am J Public Health (2013) 0.92
Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology (1983) 2.20
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
New approaches to robotics. Science (1991) 1.87
Beam hardening in x-ray reconstructive tomography. Phys Med Biol (1976) 1.65
T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology (1999) 1.52
Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology (1990) 1.51
Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med (1997) 1.46
In vitro osteoblast response to ferritic stainless steel fiber networks for magneto-active layers on implants. J Biomed Mater Res A (2012) 1.42
Driving whilst plastered: is it safe, is it legal? A survey of advice to patients given by orthopaedic surgeons, insurance companies and the police. Injury (2004) 1.39
A quantitative theory of the Hounsfield unit and its application to dual energy scanning. J Comput Assist Tomogr (1977) 1.36
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Principles of computer assisted tomography (CAT) in radiographic and radioisotopic imaging. Phys Med Biol (1976) 1.31
T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med (1996) 1.28
The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med (1996) 1.27
Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med (1999) 1.15
In vitro assessment of the biological response to nano-sized hydroxyapatite. J Mater Sci Mater Med (2004) 1.14
Tissue signatures with dual-energy computed tomography. Radiology (1979) 1.13
Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J Magn Reson Imaging (1994) 1.13
Statistical limitations in x-ray reconstructive tomography. Med Phys (1976) 1.10
Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol (1987) 1.10
Explanation of cerebral white--gray contrast in computed tomography. J Comput Assist Tomogr (1980) 1.07
Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol (2011) 1.07
A simple technique to reduce fogging of a standard visor face mask. Ann R Coll Surg Engl (2005) 1.07
Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med (1982) 1.06
Frequency dependence of MR relaxation times. II. Iron oxides. J Magn Reson Imaging (1993) 1.03
T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med (1992) 1.02
PET quantitation: blessing and curse. J Nucl Med (1988) 0.99
Human osteoblast response to silicon-substituted hydroxyapatite. J Biomed Mater Res A (2006) 0.99
Barbiturates reduce human cerebral glucose metabolism. Neurology (1986) 0.96
Cerebellar diaschisis revisited: pontine hypometabolism and dentate sparing. Neurology (1992) 0.96
The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging (1996) 0.95
Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. J Comput Assist Tomogr (1988) 0.95
Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors. AJNR Am J Neuroradiol (1983) 0.95
Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci (1995) 0.95
Assessment of the biocompatibility of photosensitive polyimide for implantable medical device use. J Biomed Mater Res A (2009) 0.95
Pituitary microadenomas: a PET study. Radiology (1990) 0.93
Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem (1998) 0.93
In vivo assessment of hydroxyapatite and silicate-substituted hydroxyapatite granules using an ovine defect model. J Mater Sci Mater Med (2005) 0.93
Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol (1984) 0.91
Corrected equations for susceptibility-induced T2-shortening. J Magn Reson (1999) 0.91
T1 and T2 alterations in the brains of patients with hepatic cirrhosis. AJNR Am J Neuroradiol (1996) 0.91
Giant congenital cellular blue nevus of the scalp of a newborn with an underlying skull defect and invasion of the dura mater. Neurosurgery (1986) 0.91
Dynamic relaxometry: application to iron uptake by ferritin. J Biol Inorg Chem (2000) 0.90
Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res (1984) 0.90
Metabolic imaging of the brain stem and spinal cord: studies with positron emission tomography using 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr (1983) 0.89
White-gray matter differentiation in computed tomography. J Comput Assist Tomogr (1977) 0.89
Repair of defects in articular joints. Prospects for material-based solutions in tissue engineering. J Bone Joint Surg Br (2004) 0.89
The effects of silicate ions on human osteoblast adhesion, proliferation, and differentiation. J Biomed Mater Res B Appl Biomater (2009) 0.88
Isolation of monocytes from human peripheral blood using immuno-affinity expanded-bed adsorption. Biotechnol Bioeng (2003) 0.88
The effects of particulate bone cements at the bone-implant interface. J Bone Joint Surg Br (2001) 0.88
Serum IGF-1 concentration in diabetic retinopathy. Diabet Med (1988) 0.86
PET-FDG of untreated and treated cerebral gliomas. J Nucl Med (1988) 0.85
Regeneration and repair of tendon and ligament tissue using collagen fibre biomaterials. Acta Biomater (2011) 0.85
MR cisternography and myelography with Gd-DTPA in monkeys. Radiology (1985) 0.85
Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite. J Biomed Mater Res A (2006) 0.85
Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br (2004) 0.85
Theory of image reconstruction in computed tomography. Radiology (1975) 0.84
The use of phantom views to reduce CT streaks due to insufficient angular sampling. Phys Med Biol (1982) 0.84
T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment. Acad Radiol (1998) 0.84
Influence of nanohydroxyapatite patterns deposited by electrohydrodynamic spraying on osteoblast response. J Biomed Mater Res A (2008) 0.83
Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR Am J Neuroradiol (1983) 0.83
Deposition of nano-hydroxyapatite particles utilising direct and transitional electrohydrodynamic processes. J Mater Sci Mater Med (2008) 0.83
Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry. Invest Radiol (1998) 0.83
Proliferation and differentiation of osteoblast-like cells on apatite-wollastonite/polyethylene composites. Biomaterials (2004) 0.82
Serial measurements of CT attenuation and specific gravity in experimental cerebral edema. Radiology (1980) 0.82
A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy. Metabolism (1989) 0.82
On the relationship between computed tomography numbers and specific gravity. Phys Med Biol (1981) 0.82
Spinal cord artifacts from truncation errors during MR imaging. Radiology (1988) 0.82
Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements. Acta Orthop Scand (2001) 0.81
Detection of orthopaedic implants by airport metal detectors. Ann R Coll Surg Engl (2007) 0.81
Split-detector computed tomography: a preliminary report. Radiology (1978) 0.81
Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes (1989) 0.81
Novel deposition of nano-sized silicon substituted hydroxyapatite by electrostatic spraying. J Mater Sci Mater Med (2005) 0.81
The apical artifact: elevated attenuation values toward the apex of the skull. J Comput Assist Tomogr (1978) 0.80
Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure. Clin Auton Res (1991) 0.80
Computed tomography profiles of periventricular hypodensity in hydrocephalus and leukoencephalopathy. Radiology (1979) 0.80
Global cerebral glucose utilization is independent of brain size: a PET Study. J Comput Assist Tomogr (1987) 0.79
Inflammatory responses of human primary macrophages to particulate bone cements in vitro. J Bone Joint Surg Br (2001) 0.79
Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy. Acta Endocrinol (Copenh) (1989) 0.79
A new approach to interpolation in computed tomography. J Comput Assist Tomogr (1978) 0.78
The 1979 Nobel prize in physiology or medicine. Science (1979) 0.78
Frequency dependence of MR relaxation times. I. Paramagnetic ions. J Magn Reson Imaging (1993) 0.78
The role of surface wettability and surface charge of electrosprayed nanoapatites on the behaviour of osteoblasts. Acta Biomater (2009) 0.78
Human cerebral glucose metabolism determined by positron emission tomography: a revisit. J Cereb Blood Flow Metab (1987) 0.78
Design of a high resolution positron emission tomograph: the Neuro-PET. J Comput Assist Tomogr (1980) 0.78
Mapping of cerebral cortical strokes in Rhesus monkeys by laser Doppler spectroscopy. Med Res Eng (1980) 0.77
Correlation of experimental and clinical studies of metabolism by PET scanning. Prog Exp Tumor Res (1984) 0.77
Human diabetic serum does not stimulate bovine retinal endothelial cell growth in culture. Curr Eye Res (1989) 0.77
Potential hazards of compressed gas cylinders: a review. Anesthesiology (1978) 0.77
In vitro evaluation of nanosized carbonate-substituted hydroxyapatite and its polyhydroxyethylmethacrylate nanocomposite. J Biomed Mater Res A (2008) 0.77
Magnetoferritin. Biomineralization as a novel molecular approach in the design of iron-oxide-based magnetic resonance contrast agents. Invest Radiol (1994) 0.77
Inter-individual and intra-individual variability in TNF-alpha production by human peripheral blood cells in vitro. Cytokine (2005) 0.77
Sequential MR studies of intracerebral hematomas in monkeys. AJNR Am J Neuroradiol (1986) 0.77
Circulating levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury. J Bone Joint Surg Br (2002) 0.76
NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy. Acta Neurol Scand (1999) 0.76
Nuclear magnetic relaxation in blood. IEEE Trans Biomed Eng (1975) 0.76
Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabete Metab (1994) 0.76
PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med (1992) 0.76
Testing bone substitutes in a small animal model of revision arthroplasty. J Mater Sci Mater Med (2002) 0.76
Bone growth into a ceramic-filled defect around an implant. The response to transforming growth factor beta1. J Bone Joint Surg Br (2004) 0.75